Moderna (NASDAQ:MRNA) extended gains for the seventh consecutive trading session, with the stock closing 2.14% higher at $29.65 on Thursday.
MRNA has added 20.66% over the course of the last six trading sessions compared to a rise of 0.84% in the benchmark